Join
Live feed
·
INSIDERFilingvia Quantisnow
AEON Biopharma Inc. logo

CHIEF EXECTUIVE OFFICER Forth Marc was granted 470,692 shares, increasing direct ownership by 168% to 750,547 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AEON· AEON Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AEON (AEON Biopharma Inc.) and more on Quantisnow.